Press Release

Animal Vaccine Market to Grow with a CAGR of 8.18% through 2029

Increased prevalence of animal disease and increasing pet adoption globally is expected to drive the Global Animal Vaccine Market growth in the forecast period, 2025-2029.


According to TechSci Research report, “Animal Vaccine Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Animal Vaccine Market stood at USD 7.68 billion in 2023 and is anticipated to grow with a CAGR of 8.18% in the forecast period, 2025-2029. Growing concerns regarding food security and the rise in animal husbandry practices are driving the demand for animal vaccines in the livestock industry. The increasing demand for animal products has resulted in substantial growth in global livestock production.

Factors such as changing lifestyles, population growth, and evolving food preferences have further fueled the demand for livestock products. These factors have significantly contributed to the market's growth. Additionally, the continuous introduction of technologically advanced vaccines and the occurrence of livestock diseases have played a pivotal role in shaping the market dynamics.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Animal Vaccine Market

The increasing prevalence of zoonotic diseases, which are diseases that can be transmitted from animals to humans, poses a significant threat to human lives. As a result, there is a growing demand for animal vaccines to combat these diseases. Not only do emerging and exotic animal diseases jeopardize the health of both humans and animals, but they also have the potential to disrupt food security. The rise in both human and animal populations, coupled with environmental degradation and globalized trade and travel, creates a fertile ground for the transmission of pathogens between species. This interplay between humans, animals, and the environment creates complex challenges that must be addressed to safeguard public health. In many parts of the world, the increasing demand for animal protein has led to a significant expansion of commercial food animal production. However, this intensification of animal production also increases the risk of emerging zoonotic diseases, which can have detrimental effects on public health. Looking ahead, it is inevitable that the world will continue to face emerging disease outbreaks in the coming decades. Therefore, the role of animal vaccines in controlling and preventing these diseases becomes crucial. Animal vaccines not only protect animals from infectious agents but also help in mitigating the risk of transmission to humans.

Additionally, rising concerns about food security, coupled with increased animal husbandry practices, are contributing to the growing demand for livestock vaccines. The global increase in demand for animal products has led to a significant expansion of livestock production.

Moreover, changing food preferences driven by evolving lifestyles and population growth further boost the demand for livestock products. These factors, along with the continuous introduction of technologically advanced vaccines and occasional outbreaks of livestock diseases, are shaping the dynamics of the livestock vaccine market. Furthermore, the wider acceptance of ruminant vaccines, particularly cattle vaccines, is driven by increased outbreaks of animal diseases and the ever-growing livestock population worldwide. Animals provide not only meat and protein but also other commercial products such as milk, wool, and leather. To protect the health and well-being of animals and prevent the transmission of infectious agents, vaccines such as rabies vaccines, equine influenza virus vaccines, and foot and mouth disease vaccines are commonly used. In conclusion, the increasing prevalence of zoonotic diseases and the need for food security are driving the demand for animal vaccines. The intricate relationship between humans, animals, and the environment necessitates robust measures to control and prevent the spread of diseases. The continuous advancements in vaccine technology and the understanding of emerging diseases will play a vital role in ensuring the health and safety of both animals and humans.


The Global Animal Vaccine Market is segmented into product, animal type, route of administration, distribution channel, regional distribution, and company.

Based on its animal type, the livestock segment emerged as the dominant animal type in the global animal vaccine market. Livestock farming plays a pivotal role in meeting the growing demand for meat, dairy, and other animal-derived products worldwide. With an increasing global population and rising disposable incomes, there is a heightened demand for high-quality animal protein, driving the expansion of the livestock sector. Consequently, the need to safeguard livestock health and productivity against infectious diseases becomes paramount. Vaccination serves as a cornerstone in disease prevention and control within livestock populations, enabling farmers to mitigate the economic losses associated with disease outbreaks and maintain the overall health and productivity of their herds. Additionally, advancements in veterinary medicine and biotechnology have facilitated the development of a diverse range of vaccines tailored to address the specific health challenges faced by different livestock species, including cattle, poultry, swine, and sheep.

Based on region, North America segment is expected to grow during the forecast period. North America emerged as the dominant market and is projected to maintain its position throughout the forecast period. This dominance can be attributed to the high prevalence of livestock and zoonotic diseases, leading to substantial animal mortality. Additionally, the considerable presence of well-established pharmaceutical companies, committed to broad commercialization of their vaccines and expanding their market reach, is expected to drive market growth. Moreover, the increasing incidence of canine disorders, driving vaccination adoption, and the growing pet population in the United States are key factors contributing to the regional market's expansion. Meanwhile, Asia Pacific is anticipated to exhibit the highest growth rate during the forecast period. The projected rise in livestock population and government initiatives, particularly in developing economies, are primary drivers for market growth in the region. With a large cattle population, there is a high demand for vaccines. The market is further propelled by significant R&D investments by major players and efforts to commercialize veterinary vaccines and inoculations at affordable prices. 


Major companies operating in Global Animal Vaccine Market are:

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd.
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ouro Fino Saude Animal


Download Free Sample Report

Customers can also request for 10% free customization on this report


“Rising concerns about food security, coupled with the growing need for animal husbandry, have significantly increased the demand for livestock vaccines. As the demand for animal products continues to rise, livestock production has witnessed a global surge. Moreover, shifting food preferences driven by evolving lifestyles and population growth have further fueled the demand for high-quality livestock products. To address the evolving market dynamics, there has been a continuous introduction of technologically advanced vaccines. These innovative vaccines not only provide effective disease prevention but also contribute to the overall improvement of animal health and welfare. Additionally, outbreaks of livestock diseases have served as a wake-up call, highlighting the importance of proactive vaccination strategies and reinforcing the need for robust veterinary healthcare systems. In this ever-changing landscape, stakeholders across the livestock industry are increasingly recognizing the critical role that vaccines play in ensuring the well-being of animals and the sustainability of livestock production. By investing in research and development, leveraging technological advancements, and fostering collaborations, the industry is poised to meet the growing demand for livestock vaccines and address the emerging challenges in a proactive and efficient manner.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion, Others), By Route Of Administration (Subcutaneous, Intramuscular, Intranasal), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Animal Vaccine Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Animal Vaccine Market.



TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]


Relevant News